BVS (STOCKS)
Bioventus Inc. Class A Common Stock
$8.100000
+0.020000 (+0.25%)
Prev close: $8.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert Claypoole
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $670.38M
- Employees
- 950
- P/E (TTM)
- 71.95
- P/B (TTM)
- 3.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.15 | $0.12 | +0.0338 | +29.09% |
|
Jun 2025 (Q2)
|
$0.21 | $0.21 | -0.0021 | -0.99% |
|
Mar 2025 (Q1)
|
$0.08 | $0.02 | +0.0564 | +238.98% |
|
Dec 2024 (Q4)
|
$0.15 | $0.08 | +0.0658 | +78.15% |
Financial Statements
| Revenues | $563.83M |
| Benefits Costs and Expenses | $549.10M |
| Cost Of Revenue | $181.80M |
| Costs And Expenses | $549.10M |
| Gross Profit | $382.03M |
| Nonoperating Income/Loss | -$30.68M |
| Operating Expenses | $336.62M |
| Selling, General, and Administrative Expenses | $315.24M |
| Depreciation and Amortization | $6.20M |
| Research and Development | $12.07M |
| Other Operating Expenses | $3.12M |
| Operating Income/Loss | $45.41M |
| Income/Loss From Continuing Operations After Tax | $9.64M |
| Income/Loss From Continuing Operations Before Tax | $14.73M |
| Income Tax Expense/Benefit | $2.16M |
| Net Income/Loss | $12.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $2.40M |
| Net Income/Loss Attributable To Parent | $10.17M |
| Net Income/Loss Available To Common Stockholders, Basic | $10.17M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.16 |
| Diluted Earnings Per Share | $0.16 |
| Basic Average Shares | 66,795,699 |
| Diluted Average Shares | 69,104,679 |
| Assets | $701.59M |
| Current Assets | $280.90M |
| Inventory | $96.27M |
| Other Current Assets | $184.63M |
| Noncurrent Assets | $420.69M |
| Intangible Assets | $377.40M |
| Other Non-current Assets | $43.29M |
| Liabilities | $494.34M |
| Current Liabilities | $161.75M |
| Accounts Payable | $26.65M |
| Other Current Liabilities | $135.10M |
| Noncurrent Liabilities | $332.59M |
| Equity | $207.26M |
| Equity Attributable To Noncontrolling Interest | $41.16M |
| Equity Attributable To Parent | $166.10M |
| Liabilities And Equity | $701.59M |
| Net Cash Flow From Operating Activities | $56.03M |
| Net Cash Flow From Operating Activities, Continuing | $56.03M |
| Net Cash Flow From Investing Activities | $21.44M |
| Net Cash Flow From Investing Activities, Continuing | $21.44M |
| Net Cash Flow From Financing Activities | -$76.55M |
| Net Cash Flow From Financing Activities, Continuing | -$76.55M |
| Exchange Gains/Losses | -$1.83M |
| Net Cash Flow | -$910.00K |
| Net Cash Flow, Continuing | $915.00K |
| Comprehensive Income/Loss | $9.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $1.85M |
| Comprehensive Income/Loss Attributable To Parent | $7.89M |
| Other Comprehensive Income/Loss | -$2.83M |